Interní Med. 2015; 17(3): 123-127

Endovascular treatment for acute iliofemoral venous thrombosis

MUDr.Miroslav Chochola, CSc.
II. interní klinika kardiologie a angiologie 1. LF UK a VFN Praha

Iliofemoral thrombosis is the most severe form of deep venous thrombosis. The patients are at an immediate risk of pulmonary embolism

and venous limb ischaemia and, prospectively, of post-thrombotic syndrome. The management of acute and chronic complications with

conservative anticoagulation therapy alone is mostly unsatisfactory. In selected patients presenting with phlegmasia, endovascular

treatment with local thrombolysis/mechanical thrombectomy is currently recommended as an alternative to anticoagulation therapy.

Iliac vein compression syndrome (May-Thurner syndrome) has to be addressed at the end of the procedure by means of percutaneous

angioplasty and stenting. Endovascular treatment in the hands of an experienced team of interventional angiologists appears to be

a highly effective and safe method for the treatment of iliofemoral thrombosis.

Keywords: Iliofemoral venous thrombosis, May-Thurner syndrome, endovascular treatment, thrombolysis, angioplasty, stent

Published: June 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Chochola M. Endovascular treatment for acute iliofemoral venous thrombosis. Interní Med. 2015;17(3):123-127.
Download citation

References

  1. Carter CJ, Anderson FA, Wheeler HB. Epidemiology and pathophysiology of venous thromboembolism In: Hull R: ed. Venous Thromboembolism, New York: Futura, 1996, Chapter 1, p. 1.
  2. Kahn SR, Partsch H, Vedantham S, et al. on behalf of the Subcommitee on the Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization. J Thromb Haemost. 2009; 7: 879-838. Go to original source...
  3. Prandoni P, Lensing AW, Prins MH, et al. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med. 2004; 141: 249-256. Go to original source...
  4. Kahn SR, Shbaklo H, Lamping DL, et al. Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost. 2008; 6: 1105-1112. Go to original source... Go to PubMed...
  5. Comerota AJ. Venous thromboembolism. In Rutherford R.B.: Vascular Surgery. 4th ed. Philadelphia, WB Saunders, 1995; 1785-1790.
  6. Grabowski E. Thrombolysis, flow, and vessel wall interactions. J Vasc Interv Radiol 1995; 6: 25-29. Go to original source...
  7. Mewissen MW, Seabrook GR, Meissner MH, et al. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: Report of National Multicenter Registry. Radiology 1999; 211: 39-49. Go to original source... Go to PubMed...
  8. May R, Thurner J. The cause of the predominately sinistral occurrence of thrombosis ofvthe pelvic veins. Angiology 1957; 8: 419-427. Go to original source... Go to PubMed...
  9. Ferris EJ, Lim WN, Smith PL, et al. May-Thurner syndrome. Radiology 1983; 1147: 29-31. Go to original source...
  10. Semba CP, Dake MD. Ileofemoral deep venous thrombosis: Agressive therapy with catheter-directed thrombolysis. Radiology 1994; 191: 487-494. Go to original source... Go to PubMed...
  11. Dotter CT, Rosch J, Seaman AJ. Selective clot lysis with low dose streptokinase. Radiology 1974; 111: 31-37. Go to original source... Go to PubMed...
  12. Kandarpa K, Drinker PA, Singer SJ, et al. Forceful pulsatile local infusion of enzyme accelerates thrombolysis: in vivo evaluation of new delivery system. Radiology 1988; 168: 739-744. Go to original source... Go to PubMed...
  13. Ouriel K, Shortell CK, Azodo MV, et al. Acute peripheral arterial occlusion: predictoss of succes in catheter-directed thrombolytic therapy. Radiology 1994; 193: 561-566. Go to original source... Go to PubMed...
  14. Comerota AJ, Gravett MH. Iliofemoral venous thrombosis. J Vasc Surg 2007; 46: 1065-1076. Go to original source...
  15. Janssen MC, Wollersheim H, Schultze-Kool LJ, et al. Local and systemic thrombolytic therapy for acute deep venous thrombosis. Neth J Med 2005; 63: 81-90.
  16. Strandness Jr DE, Langlois Y, Cramer M, et al. Long-term sequelae of acute venous thrombosis. JAMA 1983; 250: 1289-1292. Go to original source...
  17. Meissner MH. Thrombolytic therapy for acute deep vein thrombosis and the venous registry. Rev Cardiovasc Med 2002; 3(Suppl. 2): S53-60. Go to PubMed...
  18. Ulander VM, Lehtola A, Kaaja R. Long-term outcome of deep venous thrombosis during pregnancy treated with unfractionated heparin or low molecular weight heparin. Thromb Res 2003; 111: 239-242. Go to original source...
  19. Sharifi M, Mehdipour M, Bay C, et al. Endovenous therapy for deep venous thrombosis: the TORPEDO trial. Catheter Cardiovasc Interv. 2010; 76: 316-325. Go to original source...
  20. Sharafuddin MJ, Shiliang Sun S, Hoballah JJ, et al. Endovascular management of venous thrombotic and occlusive diseases of the lower extremities. JVIR, 2003; 14: 405-423. Go to original source... Go to PubMed...
  21. Meissner MH, Gloviczki P, Comerota AJ, et al. Early thrombus removal strategies for acute deep venous thrombosis: clinical practice guidelines of the Society for Vascular Surgery andthe American Venous Forum. J Vasc Surg, 2012; 55: 1449-1462. Go to original source...
  22. Jaff MR, McMurtry MS, Archer SL, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011; 123: 1788-1830. Go to original source...
  23. Enden T, Haig Y, Kl?w NE, et al. CaVenT Study Group. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet. 2012; 379: 31-38. Go to original source...
  24. Suresh V, Vedantham S, Goldhaber SZ, et al. Rationale and design of the ATTRACT Study: A multicenter randomized trial to evaluace pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis.Am Heart J 2013; 165: 523-530. Go to original source...
  25. Kearon C, Akl EA, Comerota AJ, at al. American College of Chest Physicians. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141: e419S-494S. Chest. 2012; 142: 1698-1704. Go to original source...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.